Suppr超能文献

MR-proADM 用于检测感染中的特定类型的器官衰竭。

MR- proADM to detect specific types of organ failure in infection.

机构信息

Clinical Analysis Service, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

Intensive Care Medicine Unit, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

出版信息

Eur J Clin Invest. 2020 Jun;50(6):e13246. doi: 10.1111/eci.13246. Epub 2020 May 19.

Abstract

BACKGROUND

Following the SEPSIS-3 consensus, detection of organ failure as assessed by the SOFA (Sequential Organ Failure Assessment) score, is mandatory to detect sepsis. Calculating SOFA outside of the Intensive Care Unit (ICU) is challenging. The alternative in this scenario, the quick SOFA, is very specific but less sensible. Biomarkers could help to detect the presence of organ failure secondary to infection either in ICU and non-ICU settings.

MATERIALS AND METHODS

We evaluated the ability of four biomarkers (C-Reactive protein (CRP), lactate, mid-regional proadrenomedullin (MR-proADM) and procalcitonin (PCT)) to detect each kind of organ failure considered in the SOFA in 213 patients with infection, sepsis or septic shock, by using multivariate regression analysis and calculation of the area under the receiver operating curve (AUROC).

RESULTS

In the multivariate analysis, MR-proADM was an independent predictor of five different failures (respiratory, coagulation, cardiovascular, neurological and renal). In turn, lactate predicted three (coagulation, cardiovascular and neurological) and PCT two (cardiovascular and renal). CRP did not predict any of the individual components of SOFA. The highest AUROCs were those of MR-proADM and PCT to detect cardiovascular (AUROC, CI95%): MR-proADM (0.82 [0.76-0.88]), PCT (0.81 [0.75-0.87] (P < .05) and renal failure: MR-proADM (0.87 [0.82-0.92]), PCT (0.81 [0.75-0.86]), (P < .05). None of the biomarkers tested was able to detect hepatic failure.

CONCLUSIONS

In patients with infection, MR-proADM was the biomarker detecting the largest number of SOFA score components, with the exception of hepatic failure.

摘要

背景

根据 SEPSIS-3 共识,必须通过 SOFA(序贯器官衰竭评估)评分来检测器官衰竭,以检测败血症。在重症监护病房(ICU)之外计算 SOFA 评分具有挑战性。在这种情况下的替代方法是快速 SOFA,它非常特异但灵敏度较低。生物标志物可帮助在 ICU 和非 ICU 环境中检测继发于感染的器官衰竭的存在。

材料和方法

我们通过多元回归分析和计算接收器操作特征曲线下的面积(AUROC),评估了四种生物标志物(C 反应蛋白(CRP)、乳酸、中区域促肾上腺皮质激素原(MR-proADM)和降钙素原(PCT))在 213 例感染、败血症或败血症性休克患者中检测 SOFA 考虑的每一种器官衰竭的能力。

结果

在多元分析中,MR-proADM 是五种不同衰竭(呼吸、凝血、心血管、神经和肾)的独立预测因子。反过来,乳酸预测了三种(凝血、心血管和神经)和 PCT 两种(心血管和肾)。CRP 不能预测 SOFA 的任何单独成分。MR-proADM 和 PCT 检测心血管衰竭(AUROC,CI95%)的 AUROCs 最高:MR-proADM(0.82 [0.76-0.88]),PCT(0.81 [0.75-0.87](P<.05)和肾功能衰竭:MR-proADM(0.87 [0.82-0.92]),PCT(0.81 [0.75-0.86])(P<.05)。测试的生物标志物均无法检测肝衰竭。

结论

在感染患者中,MR-proADM 是检测 SOFA 评分成分数量最多的生物标志物,除了肝衰竭。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验